2,842
edits
Psychedelics: Difference between revisions
m
no edit summary
mNo edit summary |
|||
| Line 204: | Line 204: | ||
There are a category of patients that have specific conditions or are taking specific medicines that should be [[Psychedelic Therapy Inclusion and Exclusion Criteria|excluded from psychedelic therapy]]. In general these patients have the following characteristics: | There are a category of patients that have specific conditions or are taking specific medicines that should be [[Psychedelic Therapy Inclusion and Exclusion Criteria|excluded from psychedelic therapy]]. In general these patients have the following characteristics: | ||
* People taking '''olanzapine''' (an atypical | * People taking '''quetiapine, risperidone, and olanzapine''' (an atypical antipsychotics) as there is some evidence to suggest it can [[Trip Terminator|''terminate'' a trip]]<ref>'''Olanzapine as the ideal “trip terminator”?''' Giuseppe Valeriani, Ornella Corazza, Francesco Saverio Bersani. First published: 28 July 2015 <nowiki>https://doi.org/10.1002/hup.2431</nowiki>. Accessed via: <nowiki>https://onlinelibrary.wiley.com/doi/10.1002/hup.2431</nowiki></ref>; | ||
* People taking 5HT2AR high affinity antidepressants such as '''amitriptyline''', '''mirtazapine''', and '''trazodone'''.<ref>'''The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation.''' K.H. Preller, M. Herdener, T. Pokorny, A. Planzer, R. Kraehenmann, P. Stämpfli, ''et al.'' https://www.sciencedirect.com/science/article/pii/S096098221631510X</ref> | |||
* Presence of high degrees of '''[[Psychedelic Anxiety Syndrome|Psychedelic Anxiety Syndrome;]]''' | * Presence of high degrees of '''[[Psychedelic Anxiety Syndrome|Psychedelic Anxiety Syndrome;]]''' | ||
* Presence or history of '''psychosis'''; | * Presence or history of '''psychosis'''; | ||